WCN26-8216 Malignancy prevalence in dialyzed patients evaluated for kidney transplantation and actively waitlisted

Read full text Summarise with VIRAT
Authors: Sławomir Jerzy Małyszko, Letycja Róg, Jacek S. Malyszko, Ewa Wojtaszek, Paweł Żebrowski, Jolanta Małyszko
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The overall incidence of malignancy in patients with end-stage kidney disease (ESKD) is reportedly higher compared to the general population. Cancer remains one of the dominant causes of death in these patients, due in part to uremia-induced impairment of tumor immune surveillance. Kidney transplantation is the optimal therapy for end-stage kidney failure. As patients with kidney disease often have significant comorbidities, the evaluation of a potential kidney transplant recipient should be as efficient and cost-effective as possible.

Fields of Study & Subjects

Dialysis and Renal Disease Management Renal Transplantation Outcomes and Treatments Global Cancer Incidence and Screening

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105971–105971
Publication date
25 March 2026
Language
EN